KD Logo

Analysts review Adma Biologics Inc’s rating

In a filing, Adma Biologics Inc revealed its Director ELMS STEVE unloaded Company’s shares for reported $2.5 million on Mar 19 ’24. In the deal valued at $6.08 per share,411,829 shares were sold. As a result of this transaction, ELMS STEVE now holds 2,115,671 shares worth roughly $18.64 million.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Then, ELMS STEVE sold 49,887 shares, generating $299,821 in total proceeds. Upon selling the shares at $6.01, the Director now owns 2,527,500 shares.

Before that, ELMS STEVE sold 183,008 shares. Adma Biologics Inc shares valued at $1,099,878 were divested by the Director at a price of $6.01 per share. As a result of the transaction, ELMS STEVE now holds 2,577,387 shares, worth roughly $22.71 million.

A number of analysts have revised their coverage, including Mizuho’s analysts, who began to cover the stock in mid October with a ‘”a Buy”‘ rating. Raymond James also remained covering ADMA and has increased its forecast on November 11, 2021 with a “Strong buy” recommendation from previously “an Outperform” rating. Cantor Fitzgerald started covering the stock on November 09, 2021. It rated ADMA as “an Overweight”.

Price Performance Review of ADMA

On Friday, Adma Biologics Inc [NASDAQ:ADMA] saw its stock jump 27.13% to $8.81. Over the last five days, the stock has gained 29.37%. Adma Biologics Inc shares have risen nearly 94.91% since the year began. Nevertheless, the stocks have risen 146.78% over the past one year. While a 52-week high of $6.97 was reached on 05/10/24, a 52-week low of $3.06 was recorded on 01/03/24. SMA at 50 days reached $6.37, while 200 days put it at $4.71. A total of 11.68 million shares were traded, compared to the trading of 3.02 million shares in the previous session.

Levels Of Support And Resistance For ADMA Stock

The 24-hour chart illustrates a support level at 8.17, which if violated will result in even more drops to 7.54. On the upside, there is a resistance level at 9.23. A further resistance level may holdings at 9.66. The Relative Strength Index (RSI) on the 14-day chart is 87.12, which indicates overbought technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.70, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 7.53%. Stochastics %K at 91.57% indicates the stock is a selling.

The most recent change occurred on June 04, 2019 when Jefferies began covering the stock and recommended ‘”a Buy”‘ rating along with a $8 price target.

Most Popular